Stanley Bukofzer
2019 - Assertio Holdings
In 2019, Stanley Bukofzer earned a total compensation of $1.7M as Former Senior Vice President and Chief Scientific and Technical Officer at Assertio Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $247,833 |
|---|---|
| Salary | $500,016 |
| Stock Awards | $925,291 |
| Other | $14,120 |
| Total | $1,687,260 |
Bukofzer received $925.3K in stock awards, accounting for 55% of the total pay in 2019.
Bukofzer also received $247.8K in non-equity incentive plan, $500K in salary and $14.1K in other compensation.
Rankings
In 2019, Stanley Bukofzer's compensation ranked 6,746th out of 13,971 executives tracked by ExecPay. In other words, Bukofzer earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,746 out of 13,971 | 52nd |
Division Manufacturing | 2,569 out of 5,701 | 55th |
Major group Chemicals And Allied Products | 940 out of 2,200 | 57th |
Industry group Drugs | 795 out of 1,886 | 58th |
Industry Pharmaceutical Preparations | 582 out of 1,398 | 58th |
Source: SEC filing on April 12, 2021.
Bukofzer's colleagues
We found two more compensation records of executives who worked with Stanley Bukofzer at Assertio Holdings in 2019.
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019